Tesla was the worst performing stock in the Cheddar 50 Wednesday, falling more than 7 percent to its lowest level in more than a year. Shares of the electric automaker were plagued by a downgrade by Moody’s, a crash investigation, and a backlogged production line. “All those things combined with a skittish technology market...is really weighing on the shares,” explained Efraim Levy, and analyst at CFRA. On Tuesday, the National Transportation Safety Board announced it is opening an investigation into a fatal car crash involving a Tesla in California last week. The company hasn’t been able to provide many details about what happened and is still “unclear if automated control system was active at time of crash.” This would be Tesla’s second NTSB investigation in as many years. Also on Tuesday, Moody’s downgraded Tesla’s credit rating because of a “significant shortfall in the production rate of the company’s Model 3 electric vehicle,” the agency said in a release. This delay may then force the company to seek out extra funding. However, some experts and investors remain bullish on the carmaker’s long term outlook. CFRA maintains its hold position on the shares. “Ultimately, the direction that we’re going is more electrification,” said Levy. “I would never bet against Elon Musk’s ability to raise capital,” said Frederic Lambert, Editor-in-chief of Electrek. “Historically, he’s been very consistent on that front.” For the full interview, [click here](https://cheddar.com/videos/cfras-efraim-levy-explains-why-he-maintains-hold-opinion-on-tesla).

Share:
More In Technology
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Technological Breakthrough in Head Injury Prevention
Dr. Michael Bottlang and Dr. Steve Madey, co-founders of WaveCel, join Cheddar Innovates to share their breakthrough in hard hat design that could have ramifications for protecting against head trauma across industries.
3D Printing Meets Vitamins
Melissa Snover, Founder & CEO of Nourished, joins Cheddar Innovates to discuss her one-of-a-kind business that offers customizable, 3D printed vitamins that offer less hassle, cost, and waste than traditional vitamins.
Mental Health Platform Real Announces Funding Round of $37 Million, Newly Appointed Adviser Megan Rapinoe
Mental health platform Real recently raised $37 million in a Series B round led by Owl Ventures. Through its mobile app, Real says it provides mental health care at a lower cost than traditional therapy and aims to make mental wellness a part of everyone's daily routine. The company also announced that U.S. soccer star Megan Rapinoe will serve as an adviser to the company. Ariela Safira, Founder & CEO of Real, joins Cheddar News' Closing Bell to discuss.
Need2Know: Musk Mocks Twitter Employee, George Floyd Probe & Drought
Catching you up on what you need to know on April 28, 2022, with Elon Musk mocking Twitter's top legal exec Vijaya Gadde on the platform itself, a probe in George Floyd's death finding discrimination within the Minneapolis police force, the latest California drought leading to new water restrictions, and more.
Load More